Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases by Polascik, Thomas J., Given, Robert W., Metzger, Charles, Julian, Sydney R., Vestal, James C., Karlin, Gary S., Barkley, Craig S., Bilhartz, David L., McWhorter, Laura T., Lacerna, Leo V.

Get full text

Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP by YOUNG, C. Y.-F, MONTGOMERY, B. T, ANDREWS, P. E, SHUDONG QIU, BILHARTZ, D. L, TINDALL, D. J

Get full text

Bile Acids Regulate Hepatic Low Density Lipoprotein Receptor Activity in the Hamster by Altering Cholesterol Flux across the Liver by Spady, David K., Stange, Eduard F., Bilhartz, Lyman E., Dietschy, John M.

Get full text

Low density lipoprotein-receptor activity is lost in vivo in malignantly transformed renal tissue by Clayman, Ralph V., Bilhartz, Lyman E., Spady, David K., Buja, L.Maximilian, Dietschy, John M.

Get full text

Renal cell carcinoma in the Wistar-Lewis rat: a model for studying the mechanisms of cholesterol acquisition by a tumor in vivo by CLAYMAN, R. V, BILHARTZ, L. E, BUJA, L. M, SPADY, D. K, DIETSCHY, J. M

Get full text